Australia’s CannPal Animal Therapeutics Limited (ASX:CP1) has announced it has commenced its Phase 2A pilot dose determination study for its … Read More

The post CannPal Progressing Canine Cannabinoid Trials appeared first on Dagga Magazine.

…read more